Michael Hiltzik: A new initiative by Biden that might finally bring drug prices down
The most frustrating thing about America's failure to rein in drug prices is that a weapon against Big Pharma's profiteering has been hiding in plain sight — and never used — for more than 40 years.
But it's now being unsheathed by the Biden White House.
We're talking about a provision of the Bayh-Dole Act of 1980, which was enacted to give private enterprise more latitude to exploit government-funded research in the public interest.
After resisting for years calls to apply rights granted the government by Bayh-Dole to bring down drug prices, President Joe Biden has reversed himself. On Dec. 8, the administration issued a proposal to do just that for public comment.
This could be a major step toward bringing drugmakers' pricing decisions back to Earth, and one that doesn't require congressional action.
You’re reading a preview, subscribe to read more.
Start your free 30 days